Phase 4 Depression and Anxiety Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- High school students aged 13 and older who are enrolled at Mtshabezi or Matopo High Schools in the Gwanda and Matobo Rural Districts during the five-year project period.
- Students who are able to understand and answer questions on the Youth Risk Behavior questionnaire and the PHQ-9 scale.
- Students who have a relevant history of HPV vaccination and whose parent or guardian has given consent for them to take part.
- Women and young female adults aged 13 to 45 who are visiting selected health facilities for prenatal, post-partum, family planning, or other care during the five-year project period.
- Women who have not previously received the Hepatitis B or HPV vaccine and have no known medical reasons preventing them from receiving either vaccine.
- Women who are able to understand and answer questions on the PHQ-9 and Edinburgh Postnatal Depression scales.
- All participants must have valid consent to take part in the study.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- Males who are not enrolled in the participating high schools.
- Children under the age of 13 who are not enrolled in high school and are not seeking prenatal, post-partum, or family planning services at the selected health facilities during the project period.
- Anyone who does not have valid consent to participate.
- Anyone who a doctor or midwife has determined should not participate due to a known medical condition that could cause harm to the participant or staff.
- Anyone who is unable to understand and respond to the questions being asked.
- Anyone with proof of having already received the relevant vaccinations will not be eligible for the vaccination part of this study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Elopy Sibanda, M.D, National University of Science and Technology, Zimbabwe
Phone: 4437106077
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Human Papilloma Virus infection; Hepatitis B immunity; cancer of cervix; Cancer of the liver
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.